Journal of International Medical Research · 2014 · 10 citations · 29 references
MedicineOncologyPathologyMolecular OncologyNeoplasiaTumor PathologyAngiogenesisAngiogenesis In CancerKidney CancerMalignant NeoplasmsRenal Cell CarcinomaRenal NeoplasmsAngiogenesis In NeoplasmsAngiogenesis In Renal NeoplasmsFactor Viii ActivationFactor Viii AlterationsRenal Cell Carcinoma BiomarkersTumor NeovascularizationVascular Endothelial Growth FactorVascular Endothelial Growth Factor Receptors
OBJECTIVE: *These authors contributed equally to this work. To study the relationship between tumour angiogenesis and expression of cyclo-oxygenase (COX)-2 and vascular endothelial growth factor (VEGF)-A in human renal cell carcinoma. METHODS: Archival samples of primary human renal cell carcinoma tissue and surrounding normal renal tissue (control samples) obtained from patients diagnosed with renal cell carcinoma were analysed for COX-2 and VEGF-A expression by immunohistochemistry using specific monoclonal antibodies. Tumour microvasculature was examined using factor VIII-related antigen antibody staining. RESULTS: A total of 33 renal cell carcinoma and 12 control renal tissue specimens were included. COX-2 and VEGF-A genes were overexpressed in tumour specimens compared with normal epithelia. A significant correlation was found between COX-2 and VEGF-A expression. Microvessel density was found to be increased in tumour tissues that expressed COX-2 and VEGF-A. CONCLUSION: Microvessel density was increased in tumour tissues that expressed COX-2 and VEGF-A, suggesting that COX-2 and VEGF-A are related to tumour angiogenesis in human renal cell carcinoma.
29
Molecular pathology of cyclooxygenase-2 in neoplasia.
E Fosslien · PubMed · 2000 · 400 citations
Medicine, Oncology, Pharmacology +15